CoChat

An FDG-PET-based machine learning framework to support neurologic decision-making in Alzheimer disease and related disorders

Open access

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND OBJECTIVES: Distinguishing neurodegenerative diseases is a challenging task requiring neurologic expertise. Clinical decision support systems (CDSSs) powered by machine learning (ML) and artificial intelligence can assist with complex diagnostic tasks by augmenting user capabilities, but workflow integration poses many challenges. We propose that a modeling framework based on fluorodeoxyglucose PET (FDG-PET) imaging can address these challenges and form the basis of an effective CDSS for neurodegenerative disease. METHODS: This retrospective study focused on FDG-PET images in a discovery cohort drawn from 3 research studies plus routine clinical patients. When selecting research study participants, the inclusion criterion was the availability of an FDG-PET image from within 2.5 years of diagnosis with 1 of 9 specific neurodegenerative syndromes or designation as unimpaired. Participants from disease groups were recruited from the clinical patient population while unimpaired participants came primarily from a population study. The discovery cohort was used to develop a clinical decision support framework we call StateViewer, which applies a neighbor matching algorithm to detect the presence of 9 different neurodegenerative phenotypes. The ML performance of this framework was evaluated in the discovery cohort by nested cross-validation and externally validated in the Alzheimer's Disease Neuroimaging Initiative. Potential for clinical integration was demonstrated in a radiologic reader study focused on differentiating posterior cortical atrophy from Lewy body dementia. RESULTS: The discovery cohort contained 3,671 individuals with a mean age of 68 years and consisted of 49% reported female. Our model framework was able to detect the presence of 9 different neurodegenerative phenotypes with a sensitivity of 0.89 ± 0.03 and an area under the receiver operating characteristic curve of 0.93 ± 0.02. In the radiologic reader study, readers using our model were found to have 3.3 ± 1.1 times greater odds of making a correct diagnosis than readers using a current standard-of-care workflow. DISCUSSION: Our proposed framework provides strong classification performance with high interpretability, and it addresses many of the challenges that face clinical integration of ML-based decision support tools. One limitation of this study is a uniform discovery cohort that is not representative of other patient populations in some regards.

Overview

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000213831

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 50 references

Research works printed but not linked: 1

  1. US Food and Drug Administration. Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff. Accessed Jul 1, 2024.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software

Cited by

See all 25

Metadata

Authors
Barnard, L., Botha, H., Corriveau-Lecavalier, N., Graff-Radford, J., Dicks, E., Gogineni, V., Zhang, G., Burkett, B. J., Johnson, D. R., Huls, S. J., Khurana, A., Stricker, J. L., Paul Min, H.-K., Senjem, M. L., Fan, W. Z., Wiste, H., Machulda, M. M., Murray, M. E., Dickson, D. W., Nguyen, A. T., Reichard, R. R., Gunter, J. L., Schwarz, C. G., Kantarci, K., Whitwell, J. L., Josephs, K. A., Knopman, D. S., Boeve, B. F., Petersen, R. C., Jack, C. R., Lowe, V. J., Jones, D. T., & Initiative, F. T. A. D. N.
Affiliations
  • Mayo Clinic (US)
  • Psychiatry and Psychology, Mayo Clinic, Rochester, MN;
  • Neurology, Mayo Clinic, Rochester, MN;
  • Radiology, Mayo Clinic, Rochester, MN;
Venue
Neurology
Published
2025-07-22
Volume
105
Issue
2
Pages
e213831-e213831
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W4411718841
Cited by
25
References
50
Citations by year
2026: 21 · 2025: 4
FWCI
16.82
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
Funders
  • Northern California Institute for Research and Education
  • National Institutes of Health
  • National Institute on Aging (R37AG011378, R01AG050603)
  • National Institute on Deafness and Other Communication Disorders (R01DC012519)
  • National Institute of Neurological Disorders and Stroke (R37 NS089757, R01NS089757)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
FDG-PET, clinical decision support systems, Alzheimer's disease and related dementias, posterior cortical atrophy, dementia with Lewy bodies, differential diagnosis, model interpretability, clinical implementation of AI, Alzheimer's Disease Neuroimaging Initiative
MeSH terms
Clinical Decision-Making, Machine Learning, Aged, Aged, 80 and over, Alzheimer Disease, Female, Humans, Male, Middle Aged, Retrospective Studies, Cohort Studies, Neurodegenerative Diseases, Fluorodeoxyglucose F18, Decision Support Systems, Clinical, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An FDG-PET-based machine learning framework to support neurologic decision-making in Alzheimer disease and related disorders. https://app.cochat.ai/papers/10.1212/wnl.0000000000213831
The paper
Barnard, L., Botha, H., Corriveau-Lecavalier, N., Graff-Radford, J., Dicks, E., Gogineni, V., Zhang, G., Burkett, B. J., Johnson, D. R., Huls, S. J., Khurana, A., Stricker, J. L., Paul Min, H.-K., Senjem, M. L., Fan, W. Z., Wiste, H., Machulda, M. M., Murray, M. E., Dickson, D. W., . . . Initiative, F. T. A. D. N. (2025). An FDG-PET-based machine learning framework to support neurologic decision-making in Alzheimer disease and related disorders. Neurology. https://doi.org/10.1212/wnl.0000000000213831

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.